In this issue:
Obesity reduces likelihood of PsA Remission
Guselkumab improves work productivity in biologic-naive patients
Favourable pregnancy outcomes in women with well managed axSpA
Physical activity linked to improved global functioning in AS
TNF inhibitor therapy mitigates risk of death in AS
Patients with PsA have an increased risk of type 2 diabetes
Diminished Omicron neutralisation capacity in COVID vaccinated rheumatic patients
SELECT AXIS 2: upadacitinib is efficacious for biologic-refractory AS
Booster COVID vaccine restores waning humoral response in patients with rheumatic disease
Long-term adherence to etanercept treatment for SpA improves effectiveness
Please login below to download this issue (PDF)